Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

Research ArticleBRAIN

Reduced N-Acetylaspartate Levels in the Frontal Cortex of 3,4-Methylenedioxymethamphetamine (Ecstasy) Users: Preliminary Results

Liesbeth Reneman, Charles B. L. M. Majoie, Herman Flick and Gerard J. den Heeten
American Journal of Neuroradiology February 2002, 23 (2) 231-237;
Liesbeth Reneman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles B. L. M. Majoie
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Herman Flick
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerard J. den Heeten
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Fig 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig 1.

    Proton density-weighted MR image (4000/22) shows the three voxel locations for the localized 1H MRS studies: midfrontal gray matter (left), mid-occipital gray matter (middle), and right parietal white matter (right).

  • Fig 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig 2.

    Proton MRS spectra from the midfrontal gray matter region in a control subject (age, 23 years) and an MDMA user (cumulative lifetime exposure, 200 tablets; age, 26 years). The spectrum in the MDMA user is representative for the whole group and shows a reduction in NAA levels, with Cr levels similar to those in the control subject. Note that MI levels are elevated in this specific MDMA user, although for the group as a whole, mean MI measures in MDMA users did not statistically differ from those of control subjects.

  • Fig 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig 3.

    Plot shows the correlation between the NAA/Cr ratio in the frontal cortex and the extent of previous MDMA use.

Tables

  • Figures
    • View popup
    TABLE 1:

    Demographic data and characteristics of MDMA users and control subjects

    CharacteristicControl Subjects(N = 12)MDMA Users(N = 15)
    Age (y)27.0 ± 4.127.2 ± 5.3
    MDMA use
      Duration (y)NA5.6 (2.5–12.0)
      Usual dose (no. of tablets)NA2.1 (1.5–3.5)
      Lifetime dose (no. of tablets)NA723 (55–2176)
      Time since last tablet (wk)NA12.0 (1–40)
    Other drugs
      Alcohol (units per wk)13.4 ± 11.917.5 ± 13.8
      Tobacco (no. of cigarettes per day)10.8 ± 3.713.3 ± 14.9
      Cannabis (no. of joints in the last 3 mo)2.3 ± 0.5158.3 ± 178.9*
      Amphetamine (no. of uses in the last 3 mo)NA5.0 ± 8.7
    • Note.—Data are the means ± SDs or means (ranges). NA indicates not applicable.

    • * The difference between MDMA users and control subjects was statistically significant (P < .01, unpaired Student t test).

    • View popup
    TABLE 2:

    1H MRS findings in gray and white matter regions in MDMA users and control subjects

    Voxel LocationControl Subjects* (N = 12)MDMA Users* (N = 15)Difference (%)P Value†
    Gray matter ratios‡
      Midfrontal
        NAA/Cr1.62 ± 0.201.43 ± 0.21−11.7.04
        NAA/Cho2.06 ± 0.231.78 ± 0.27−14.0.03
        MI/Cr0.65 ± 0.080.64 ± 0.06−1.5.62
      Midoccipital
        NAA/Cr1.56 ± 0.191.54 ± 0.21−0.1.72
        NAA/Cho3.04 ± 0.522.67 ± 0.61−12.2.12
        MI/Cr0.60 ± 0.070.57 ± 0.08−5.0.29
    Right parietal white matter ratios§
      NAA/Cr1.90 ± 0.101.78 ± 0.19−6.3NA
      NAA/Cho1.84 ± 0.161.96 ± 0.32+6.5NA
      MI/Cr0.64 ± 0.060.62 ± 0.09−3.1NA
    • * Data are the means ± SDs.

    • † NA indicates not applicable.

    • ‡ At MANOVA, F = 2.82, df = 6.0, P = .045.

    • § At MANOVA, F = 1.79, df = 3.0, P = .180.

PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 23 (2)
American Journal of Neuroradiology
Vol. 23, Issue 2
1 Feb 2002
  • Table of Contents
  • Index by author
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Reduced N-Acetylaspartate Levels in the Frontal Cortex of 3,4-Methylenedioxymethamphetamine (Ecstasy) Users: Preliminary Results
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
Liesbeth Reneman, Charles B. L. M. Majoie, Herman Flick, Gerard J. den Heeten
Reduced N-Acetylaspartate Levels in the Frontal Cortex of 3,4-Methylenedioxymethamphetamine (Ecstasy) Users: Preliminary Results
American Journal of Neuroradiology Feb 2002, 23 (2) 231-237;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
Reduced N-Acetylaspartate Levels in the Frontal Cortex of 3,4-Methylenedioxymethamphetamine (Ecstasy) Users: Preliminary Results
Liesbeth Reneman, Charles B. L. M. Majoie, Herman Flick, Gerard J. den Heeten
American Journal of Neuroradiology Feb 2002, 23 (2) 231-237;
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Neurotoxic effects of ecstasy on the thalamus
  • The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy")
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • Statin Therapy Does Not Affect the Radiographic and Clinical Profile of Patients with TIA and Minor Stroke
  • Usefulness of Quantitative Susceptibility Mapping for the Diagnosis of Parkinson Disease
  • White Matter Alterations in the Brains of Patients with Active, Remitted, and Cured Cushing Syndrome: A DTI Study
Show more Brain

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner
  • Book Reviews

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire